The kinetics of inhibition of human and bovine a-thrombin and human factor Xa by antithrombin III were examined under pseudo-first-order conditions as a function of the concentration of pentosan polysulphate [a fully sulphated (#l-4)-linked D-xylopyranose with a single laterally positioned 4-O-methyl-c-D-glucuronic acid]. Double-reciprocal plots of the observed first-order rate constant against concentration of pentosan polysulphate gave straight lines, intercepts on the axes giving values for maximum increase in second-order rate constant (by calculation) and apparent dissociation constant. These values were: for human a-thrombin 1.52x 107M1-min-1 and 3.6pm respectively, for bovine ct-thrombin 6.56x 106MwImin-and 0.16 M and for factor Xa 6.86x 106w mImin-1 and 20M. In the presence of pentosan polysulphate the dissociation constant for the initial complex of antithrombin III and thrombin was shown to be reduced from approx. 2 x 10-3M to 61 x 10-6M without apparent change in the limiting rate constant of 750min-'. An oligosaccharide (primarily 8-10 saccharide units) prepared from heparin and with high affinity for antithrombin III but low potency in the thrombinantithrombin III interaction did not diminish the rate of interaction catalysed by pentosan polysulphate. The catalysis was shown to be due to a weak electrostatic interaction, since it was completely reversed by concentrations of NaCl greater than 0.3M. It is concluded that the mechanism is independent of the heparin high-affinity binding site on antithrombin III and is probably due to binding of the high-chargedensity polysaccharide to the proteinase. It is calculated that the acceleration in rate achieved, although lower than that of heparin, approaches that required to be of physiological significance and may be of importance in the anticoagulation role of antithrombin III at sites of high charge density which may occur in vivo.
Heparin functions as an anticoagulant primarily by accelerating the velocity at which antithrombin III neutralizes serine proteinases of the haemostatic mechanism . A number of phenomena are important in this catalysis, but a unique feature is an alteration in the conformation of the antithrombin III upon binding to a specific domain on the heparin molecule, which increases the reactivity of the inhibitor as a pseudosubstrate Casu et al., 1981; Bjork & Lindahl, 1982) .
A number of other sulphated polysaccharides have been identified as having the property of prolonging the clotting time of whole blood or plasma, and these have been grouped under the heading of heparinoids (Pulver, 1961) . One of such is a pentosan polysulphate prepared by sulphation of carbohydrate from the bark of beech trees, Fagus sylvatica. The structure of the parent polysaccharide has been elucidated as chains of (PIl-4)-linked D-xylopyranose with laterally positioned 4-O-methyl-a-D-glucuronic acid at C-2 of xylose (Aspinall, 1959) . All available hydroxy groups are occupied upon sulphation (Raveux et al., 1966) . The molecular mass has been estimated by ultracentrifugation to be 3000Da with a narrow distribution (no portion > 5000Da or < 1500Da).
The properties of the pentosan polysulphate as
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an anticoagulant show it to be of low potency as compared with heparin (Soria et al., 1980) , about 10 times less effective than heparin on a weight-toweight basis . The mechanism of its anticoagulant effect was shown to be partly independent of antithrombin III (Soria et al., 1980) , but a number of workers have shown it to accelerate the rate of interaction between antithrombin III and thrombin, and between antithrombin III and coagulation factor Xa (Czapek et al., 1980; Fischer et al., 1982) .
In this present paper we have investigated this property and have obtained evidence which, together with our previous findings (Scully & Kakkar, 1984) , suggests that the pentosan polysulphate brings about this catalysis by a mechanism which does not involve binding to the high-affinity site on antithrombin III, and may be due to binding to the proteinase.
Materials and methods
Bovine a-thrombin, human antithrombin III and human factor Xa were prepared and characterized as previously described (Scully & Kakkar, 1984; Ellis et al., 1982 Griffith (1982a) . The dis, appearance of enzyme from a mixture of inhibitor and enzyme in conditions in which the concentration of antithrombin > enzyme follows first order kinetics such that: (Griffith, 1982a; Petersen & Jorgensen, 1983 (Fig.  2a) , from which a maximum k'b5. of 5.5 minunder these conditions was calculated and an apparent dissociation constant for pentosan polysulphate of 3.6 gM. In Fig. 3 is shown the effect of the pentosan polysulphate upon the reaction rate as observed on SDS/polyacrylamide gels. As was carried out at 25°C and in the presence of substrate. The results show clearly the acceleration of the formation of the antithrombin III-thrombin complex in the presence of pentosan polysulphate (gels a, b and c) as compared with in its absence (gels d, e and I).
The effect of pentosan polysulphate on the antithrombin III-factor Xa interaction was also determined and k'br. was calculated. A plot of 1/kgb,. versus 1/[pentosan polysulphate] (Fig. 2b) was linear, intercepts on the ordinate abscissa giving values for maximum ko'b. of 2.85 min-I and Kd of 20 pM. In Fig. 2(c Samples (5Opl) were removed at 5, 10 and 20s and added to 5Opl of 0.1 M-Tris/phosphate (pH 7.0) containing 0.1% SDS at 100°C. After 2min heating the samples were cooled to room temperature and run on 7%~SDS/polyacrylamide gels according to the method of Weber & Osborn (1969) . Gels (a), (b) and (c) show the changes in electrophoretic mobility in the reaction mixture containing pentosan polysulphate and gels (d), (e) and (f) that in its absence. Gels 28.5 min-I and Kd of 66pgM were found (Fig. 4b) . In the absence of pentosan polysulphate and at concentrations of 100-500pM-antithrombin III, the inverse plot of rate constant against inhibitor extrapolated through the origin indicating a Kd of > I mm (Fig. 4a) .
Effect of antithrombin III-binding oligosaccharide derivedfrom heparin upon the acceleration ofthe antithrombin III-thrombin interaction by pentosan polysulphate An oligosaccharide containing 8-10 monosaccharide units obtained by HNO2 depolymerization of heparin, gel chromatography and separation of molecules with high affinity for antithrombin III has been shown previously to have the property of exhibiting very low potency in the antithrombin III-thrombin interaction but high potency in the antithrombin III-factor Xa interaction Oosta et al., 1981; Denton et al., 1983 k'b,. was observed, reaching a plateau at concentrations of NaCl between 0.0375 and 0.11 mM. At concentrations of NaCl beyond this the potentiation was reduced and the reaction rate was the same as the antithrombin III-thrombin control at 0.3M-NaCl (Fig. 6) . At all concentrations examined, NaCl had no significant effect on the interaction of antithrombin III with thrombin when alone, as others have shown previously (Griffith et al., 1980 ). (Kitz & Wilson, 1962 
Discussion
The results presented here show clearly a potentiation of the rate of interaction between antithrombin III and human and bovine athrombin and human factor Xa ( Table 2 ). The mechanism of inhibition of proteinases (P) by antiVol. 222 thrombin III (AT) may be considered as a two-step reaction scheme analogous to that of other serine proteinase inhibitors. The reaction is assumed to involve an initial binding interaction or Michaelis complex, P-AT, before irreversible formation of the stable P-AT* complex. Heparin has been shown previously to increase the affinity of the Michaelis complex with little or no effect on the irreversible step (Olson & Shore, 1982) . In this present study we have demonstrated that a 1 :1 molar complex between antithrombin III and thrombin is formed (Fig. 3) and that the effect of pentosan polysulphate is to increase the affinity of the Michaelis complex. The rate constant of 750min-1 in the presence of pentosan polysulphate can be compared with that found by Griffith (1982b) of 785min-t in the presence of heparin. Assuming the limiting rate constant to be the same in the absence of heparin, a dissociation constant of approx. 2 x 10-3M can be calculated (Fig. 4a) corresponding to an increased affinity of 30-fold in the presence of pentosan polysulphate.
To provide a preliminary explanation of the mechanism by which the pentosan polysulphate may be causing an increase in affinity of the antithrombin III-proteinase complex we have considered mechanisms by which heparin is thought to exert its effect on the inhibition of coagulation proteinases. There are three mechanisms for which evidence has been provided over the past years. Firstly, binding of heparin to antithrombin III causes a conformational change increasing its receptivity to interaction Li et al., 1976; Villanueva & Danishefsky, 1977; Nordenman et al., 1978) ; secondly, binding of heparin to the proteinase increases its receptivity (Machovich, 1975; Machovich et al., 1975; Smith, 1977; Hatton & Regoeczi, 1977) and thirdly, binding to antithrombin III and proteinase (in the case of thrombin and factor IXa) causes increased reactivity (Laurent et al., 1978; Pomerantz & Owen, 1978; Machovich & Aranyi, 1978; Jordan et al., 1980b; Holmer et al., 1981; Griffith, 1982b) .
From the evidence we consider that the second mechanism may explain the potentiation caused by the pentosan polysulphate. Firstly, we have shown previously that pentosan polysulphate has no effect on the binding of heparin to antithrombin III but can interfere with the binding of heparin to thrombin (Scully & Kakkar, 1984) . Data from others show that pentosan polysulphate binds to thrombin but not to antithrombin III [indicated by alterations in electrophoretic mobility (Fischer et al., 1982) ]. Secondly, a 100-fold variation in apparent dissociation constants is observed according to the proteinase involved (Kd for factor Xa 20 uM, for bovine thrombin 0.16pM), suggest- ing that the effect is related to the binding to the enzyme rather than to a common site on the antithrombin III. Thirdly, preliminary binding to the high-affinity site of an oligosaccharide derived from heparin [prepared by elution from antithrombin III-Sepharose at 0.9M-NaCl (Denton et al., 1983) ] has no significant effect on the acceleration of rate by pentosan polysulphate (Table 1) .
When the potentiation is measured in the presence of increasing concentrations of NaCl a decrease is observed at greater than 0.11 M. This shows the potentiation to arise from a weak electrostatic binding as has been shown to be the property of heparin binding to thrombin (Petersen & Jorgensen, 1983) . Although heparin binding to thrombin is necessary for the acceleration of the thrombin-antithrombin III reaction [Kd for heparin-thrombin 8 x 10-7M (Jordan et al., 1980a,b) or 3.5 x 10-8M (Griffith, 1982c Table 1 ). This property of pentosan polysulphate may be related to its high charge density, (approx. 4 sulphate groups/disaccharide unit versus 2.5 for heparin and 1.0 for chondroitin sulphate). Properties of acceleration of interaction by heparin which are independent of the antithrombin III-binding site but dependent upon charge density have recently been described for heparin cofactor II (Hurst et al., 1983) . In that paper it was shown, also, that although the catalytic effect of heparin on the antithrombin IIIthrombin interaction was primarily dependent on the antithrombin III binding sequence, increase in charge density also increased potency. Although the acceleration by pentosan polysulphate is much less than that of heparin [antithrombin III-thrombin interaction: heparin, 7000-fold calculated from Griffith (1982b) , pentosan polysulphate, 40-fold) the lower rates of acceleration may be significant in vivo. In a recent review Travis & Salvesen (1983) state that to be effective physiologically the rates of interaction of inhibitor and target enzyme in plasma should be such as to achieve a ti for enzyme activity of less than lOOms. As example, the ti of plasma due to interaction with fast a-antiplasmin in plasma at 25°C is 29ms (Wiman & Collen, 1978) . By using the maximum second-order rate constant obtained herein, ti in plasma (ignoring contribution by other plasma proteinase inhibitors) may be calculated from the formula of Bieth (1980):
Assuming a plasma concentration of antithrombin III of 4.4pM (Kueppers & Black, 1974) a value is obtained from thrombin of 909ms and for factor Xa of 1980ms. The possibility that antithrombin III may function as an inhibitor, physiologically, by a mechanism dependent upon binding of the proteinases to high-charge-density sites is in need of investigation.
